Table 1 Patient characteristics (n = 53)
Variable | CHUV | Number (%) HUG | CHCVS | p* |
|---|---|---|---|---|
Age (years) | 0.68 | |||
Median | 57 | 61 | 55 | |
Range | 48 - 73 | 41 - 76 | 25 - 78 | |
Gender | 0.99 | |||
Female | 6 (46) | 7 (26) | 5 (39) | |
Male | 7 (54) | 20 (74) | 8 (61) | |
GPA | 0.50 | |||
Median | 3.0 | 2.5 | 2.5 | |
Range | 2 - 4 | 1 - 4 | 1 - 4 | |
RPA | 0.28 | |||
1 | 5 (38) | 8 (30) | 6 (46) | |
2 | 8 (62) | 12 (44) | 5 (39) | |
3 | 0 (0) | 7 (26) | 2 (15.4) | |
Lung cancer, type | 0.03 | |||
Adenocarcinoma | 9 (69) | 17 (63) | 6 (46) | |
SCC | 1 (23) | 4 (22) | 7 (54) | |
Neuro-endocrine | 3 (8) | 6 (15) | 0 (0) | |
Number of metastasis | 0.88 | |||
1 | 12 (92) | 22 (82) | 11 (85) | |
2 - 3 | 1 (8) | 5 (18) | 2 (15) | |
Brain metastasis | 0.13 | |||
Synchronous | 21 (78) | 6 (46) | 8 (62) | |
Metachronous | 6 (22) | 7 (54) | 5 (38) | |
Brain surgery (metastatectomy) | 0.44 | |||
Yes | 11 (85) | 19 (70) | 8 (62) | |
No | 2 (15) | 8 (30) | 5 (38) | |
Dose (Gy) | < 0.01 | |||
≤ 39 | 0 | 26 | 3 | |
> 39 | 13 | 1 | 10 |